5-year Incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons

Douglas Rex, Oscar Cummings, Debra Helper, Thomas Nowak, J. M. McGill, G. Z. Chiao, P. Y. Kwo, K. T. Gottlieb, S. O. Ikenberry, F. G. Gress, Glen Lehman, L. J. Born

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Background and Aims: Cost-effectiveness of colorectal cancer screening will be maximized by selecting the widest screening intervals that effectively prevent cancer mortality. However, data on the incidence of neoplasia in persons with no abnormal findings on initial examination are limited. The aim of this study was to describe the incidence of colonic neoplasia 5 years after negative screening colonoscopy in asymptomatic average-risk persons. Methods: We previously reported the results of screening colonoscopy in 496 asymptomatic average-risk persons, 368 of whom had no neoplasia identified. Colonoscopy to the cecum was performed in 154 of these persons at a mean of 66 months after the initial negative colonoscopy. Results: Forty-one (27%) had at least one adenoma, but only 1 person had an adenoma ≤1 cm and none had cancer, severe dysplasia, or villous or tubulovillous histology. Hyperplastic polyps at the initial examination did not predict incident adenomas. Regular nonsteroidal anti-inflammatory drug use was associated with a decreased rate of incident adenomas. Conclusions: In average-risk persons, the interval between screening examinations can be safely expanded beyond 5 years, provided the initial examination is a carefully performed complete colonoscopy that is negative for colonic adenomas or cancer.

Original languageEnglish
Pages (from-to)1178-1181
Number of pages4
JournalGastroenterology
Volume111
Issue number5
DOIs
StatePublished - 1996

Fingerprint

Colonoscopy
Adenoma
Incidence
Neoplasms
Cecum
Polyps
Early Detection of Cancer
Cost-Benefit Analysis
Colorectal Neoplasms
Histology
Anti-Inflammatory Agents
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Gastroenterology

Cite this

5-year Incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. / Rex, Douglas; Cummings, Oscar; Helper, Debra; Nowak, Thomas; McGill, J. M.; Chiao, G. Z.; Kwo, P. Y.; Gottlieb, K. T.; Ikenberry, S. O.; Gress, F. G.; Lehman, Glen; Born, L. J.

In: Gastroenterology, Vol. 111, No. 5, 1996, p. 1178-1181.

Research output: Contribution to journalArticle

Rex, D, Cummings, O, Helper, D, Nowak, T, McGill, JM, Chiao, GZ, Kwo, PY, Gottlieb, KT, Ikenberry, SO, Gress, FG, Lehman, G & Born, LJ 1996, '5-year Incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons', Gastroenterology, vol. 111, no. 5, pp. 1178-1181. https://doi.org/10.1053/gast.1996.v111.pm8898630
Rex, Douglas ; Cummings, Oscar ; Helper, Debra ; Nowak, Thomas ; McGill, J. M. ; Chiao, G. Z. ; Kwo, P. Y. ; Gottlieb, K. T. ; Ikenberry, S. O. ; Gress, F. G. ; Lehman, Glen ; Born, L. J. / 5-year Incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. In: Gastroenterology. 1996 ; Vol. 111, No. 5. pp. 1178-1181.
@article{ede69cbaa5ac4860a09213a7d296e2b1,
title = "5-year Incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons",
abstract = "Background and Aims: Cost-effectiveness of colorectal cancer screening will be maximized by selecting the widest screening intervals that effectively prevent cancer mortality. However, data on the incidence of neoplasia in persons with no abnormal findings on initial examination are limited. The aim of this study was to describe the incidence of colonic neoplasia 5 years after negative screening colonoscopy in asymptomatic average-risk persons. Methods: We previously reported the results of screening colonoscopy in 496 asymptomatic average-risk persons, 368 of whom had no neoplasia identified. Colonoscopy to the cecum was performed in 154 of these persons at a mean of 66 months after the initial negative colonoscopy. Results: Forty-one (27{\%}) had at least one adenoma, but only 1 person had an adenoma ≤1 cm and none had cancer, severe dysplasia, or villous or tubulovillous histology. Hyperplastic polyps at the initial examination did not predict incident adenomas. Regular nonsteroidal anti-inflammatory drug use was associated with a decreased rate of incident adenomas. Conclusions: In average-risk persons, the interval between screening examinations can be safely expanded beyond 5 years, provided the initial examination is a carefully performed complete colonoscopy that is negative for colonic adenomas or cancer.",
author = "Douglas Rex and Oscar Cummings and Debra Helper and Thomas Nowak and McGill, {J. M.} and Chiao, {G. Z.} and Kwo, {P. Y.} and Gottlieb, {K. T.} and Ikenberry, {S. O.} and Gress, {F. G.} and Glen Lehman and Born, {L. J.}",
year = "1996",
doi = "10.1053/gast.1996.v111.pm8898630",
language = "English",
volume = "111",
pages = "1178--1181",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - 5-year Incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons

AU - Rex, Douglas

AU - Cummings, Oscar

AU - Helper, Debra

AU - Nowak, Thomas

AU - McGill, J. M.

AU - Chiao, G. Z.

AU - Kwo, P. Y.

AU - Gottlieb, K. T.

AU - Ikenberry, S. O.

AU - Gress, F. G.

AU - Lehman, Glen

AU - Born, L. J.

PY - 1996

Y1 - 1996

N2 - Background and Aims: Cost-effectiveness of colorectal cancer screening will be maximized by selecting the widest screening intervals that effectively prevent cancer mortality. However, data on the incidence of neoplasia in persons with no abnormal findings on initial examination are limited. The aim of this study was to describe the incidence of colonic neoplasia 5 years after negative screening colonoscopy in asymptomatic average-risk persons. Methods: We previously reported the results of screening colonoscopy in 496 asymptomatic average-risk persons, 368 of whom had no neoplasia identified. Colonoscopy to the cecum was performed in 154 of these persons at a mean of 66 months after the initial negative colonoscopy. Results: Forty-one (27%) had at least one adenoma, but only 1 person had an adenoma ≤1 cm and none had cancer, severe dysplasia, or villous or tubulovillous histology. Hyperplastic polyps at the initial examination did not predict incident adenomas. Regular nonsteroidal anti-inflammatory drug use was associated with a decreased rate of incident adenomas. Conclusions: In average-risk persons, the interval between screening examinations can be safely expanded beyond 5 years, provided the initial examination is a carefully performed complete colonoscopy that is negative for colonic adenomas or cancer.

AB - Background and Aims: Cost-effectiveness of colorectal cancer screening will be maximized by selecting the widest screening intervals that effectively prevent cancer mortality. However, data on the incidence of neoplasia in persons with no abnormal findings on initial examination are limited. The aim of this study was to describe the incidence of colonic neoplasia 5 years after negative screening colonoscopy in asymptomatic average-risk persons. Methods: We previously reported the results of screening colonoscopy in 496 asymptomatic average-risk persons, 368 of whom had no neoplasia identified. Colonoscopy to the cecum was performed in 154 of these persons at a mean of 66 months after the initial negative colonoscopy. Results: Forty-one (27%) had at least one adenoma, but only 1 person had an adenoma ≤1 cm and none had cancer, severe dysplasia, or villous or tubulovillous histology. Hyperplastic polyps at the initial examination did not predict incident adenomas. Regular nonsteroidal anti-inflammatory drug use was associated with a decreased rate of incident adenomas. Conclusions: In average-risk persons, the interval between screening examinations can be safely expanded beyond 5 years, provided the initial examination is a carefully performed complete colonoscopy that is negative for colonic adenomas or cancer.

UR - http://www.scopus.com/inward/record.url?scp=0029807912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029807912&partnerID=8YFLogxK

U2 - 10.1053/gast.1996.v111.pm8898630

DO - 10.1053/gast.1996.v111.pm8898630

M3 - Article

C2 - 8898630

AN - SCOPUS:0029807912

VL - 111

SP - 1178

EP - 1181

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -